Ambrosia, the controversial medical startup selling transfusions of youthful blood under the premise it confers anti-aging benefits, has swiftly ceased operations hours after the FDA issued an oblique statement suggesting the treatment has not been proven to be safe or effective.
.. Continue Reading Startup selling transfusions of young blood ceases treatments following FDA warningCategory: Science
Tags:
from New Atlas (Gizmag) http://bit.ly/2DQcvbe
No comments:
Post a Comment